The limit of detection (LOD) for any analytical procedure, the point at which analysis is just feasible, may be determined by a statisticalapproach based on measuring replicate blank (negative)samples or by an empiricalapproach, consistingof measuring progressivelymore dilute concentrations of analyte. The limitof quantitation(LOQ), or concentrationat which quantitativeresultscan be reported with a high degree of confidence, may likewise be determined by either approach. We used both methods to determine LOD and LOQ for forensic gas chromatographic-mass spectrometric (Gc-MS) analyses of abused drugs. The statistically determined LCD and LOQ values for these assays underestimated the LOD because of the large imprecisionassociated with blank measurements and the inabilityof blank samples to meet typical GC-MS acceptance criteria. The empirical method provided much more realistic LCD values, supported by reasonable experimental data, and are 0. The empirical (experimental) method consists of analyzing a series of samples containing increasingly lower concentrations of analyte. The LOD is the lowest concentration at which the results still satisfy some predetermined acceptance criteria. Below the LOD, the results fail to meet these criteria (analysis is not feasible).
conditions; the smallest amount that is clearly distinguishable from background or 'blank" (1, 3). The International Federation of Clinical Chemistry (IFCC) uses a similar definition, adding that the LOD"... defines the point at which the analysis becomes just feasible" (1, 4) . The empirical (experimental) method consists of analyzing a series of samples containing increasingly lower concentrations of analyte. The LOD is the lowest concentration at which the results still satisfy some predetermined acceptance criteria. Below the LOD, the results fail to meet these criteria (analysis is not feasible).
Needleman and Romberg (6) used this method to determine the LODs for gas chromatography-mass spectrometry (GC-MS) assays for abused drugs. They criticized the statistical method because, in effect, it measures the average noise level of the procedure and "... defines only the ability to measure nothing" [emphasis in original] instead of a very low concentration of analyte. The limit of quantit.ation (LOQ) is set at a higher concentration than the LOD; in the statistical method, it is 10 SD above the mean blank value (5), thus presenting a greater probability that a value at the LOQ is "real" and not just a random fluctuation of the blank reading.
LOD and LOQ have a special significance in forensic drug testing. The US Department of Health and Human
Services (HHS) National Laboratory Certification
Program (NLCP) requires that the LOD and LOQ be determined for GC-MS confirmatory assays to prove that analytes can be measured well below the administrative cutoff concentrations.
When a laboratory retests a sample previously confirmed positive by another laboratory that used the mandated cutoff, the LOD of the assay is used as the retesting cutoff to adjust for potential analyte deterioration during storage. We determined the LOD/LOQ by both the statistical and the empirical methods for GC-MS confirmatory assays for drugs of abuse to decide which approach is preferable for forensic testing purposes.
Materials and Methods

GC-MS assays.
We used our standard, validated GC-MS assays for 11-nor-9-tetrahydrocannabinol-9-carboxylic acid (THC), benzoylecgonine (BE), amphetamine (AMP), methamphetamine (MAMP), codeine, and morphine. Some details of the assays are summarized in Table 1 For optimal accuracy, we prepared samples by adding stock solutions to drug-free urines. However, we used concentrations equivalent to those obtained by serial dilutions because the dilution approach is easy and practical and can be used when pure analyte preparations are not available to prepare samples with known, weighed-in amounts of analyte.
Results
Preliminary studies.
The results of the initial experiments to bracket the concentration range of the LODs are given in Table 2 . For THC, the LOD appeared to be around 1.8 gfL; for BE, between 3.125 and 6.25 p.gfL;
for AMP and MAMP, between 62.5 and 125 9ugfL; for codeine, between 18.75 and 37.5 j.tgfL; and for morphine, between 4.7 and 18.75 p.gfL. Therefore, we prepared samples at about these concentrations and analyzed them on all the GC-MS systems that were validated for the respective drugs.
LOD studies. The LOD data were collected over -5 weeks. Final average values were based on at least 16 values (typically, 20), reflecting the day-to-day variability of the systems. The results are summarized in Table 3 .
Comparison of empirical and statistical LODs. Table 4 summarizes the database we used to calculate the statistical LODs. Clearly, a great deal of imprecision is associated with the statistical data, as reflected by the CVs, which range from 55% to 753%.
Comparison of empirical and statistical LOQs. or the "limit of detection" of an assay. At the risk of engaging in semantic hairsplitting, this issue deserves some comment. The NCCLS, a potential final arbiter in these matters, has culled key definitions from all NCCLS documents in a Proposed Guideline (NRSCL8-P2) (3). Only a single definition of "detection limit" is given, but seven different definitions of "sensitivity."
Most are essentially identical to that for detection limit, suggesting that the terms are used synonymously.
However, NCCLS documents also refer to sensitivity as the response of a system to small differences in analyte concentration (analytical sensitivity) and as the ability of a test to correctly identify the presence of a disease in a population (clinical sensitivity). Thus, when "sensitivity" is used, either it has to be qualified by the author or the reader must derive the specific definition from the context in which the term is used.
The IFCC's Expert Panel on Nomenclature and Principles of Quality Control in Clinical Chemistry
fails to differentiate the terms detection limit and sensitivity, describing sensitivity as the ability to detect small quantities of the measured component and referring the reader to the detection limit definition (4). to a corresponding change in analyte concentration. As the analyte concentration approaches zero, the signal disappears into noise, and the detection limit is reached.
Skoog and Leary (9) use a nearly identical definition, defining the LOD as the minimum concentration
of analyte that can be detected at a known confidence level. linear range, a laboratory should evaluate the detection limit by using its routine procedures, whether statistical or empirical.
Clearly, the terms LOD and sensitivity are not used consistently; in fact, there is some confusion, with "sensitivity" referring to three different entities: LOD, analytical sensitivity, and clinical sensitivity.
The advantage of LOD is that the very term unambiguously defines the parameter to which it refers. We suggest that LOD, or detection limit, be used to describe an assay's lowest level of reliable performance and that use of the term sensitivity for this purpose be discouraged. The more meaningful question is how best to determine the LOD. In our test situation, we found that the empirical LODs are always considerably greater than the statistical LODs. The empirical LODs are at drug concentrations that meet the routine GC-MS acceptance criteria applied in our laboratory on a daily basis and are typically used in most forensic labs. Expecting 90% or more of values to pass is probably conservative but it ensures a realistic LOD. We made it a point not to alter any of the standard GC-MS operating conditions. Changing settings for LOD studies would be inappropriate because retesting a sample is expected to be done under the same conditions as used when testing any other sample. Tweaking the system to obtain a lower LOD than possible under standard operating conditions would be open to forensic challenge.
Needleman and Romberg (6) noted in their LOD study that it was necessary to lower the integrator threshold of the MS from a setting of 125 to 10 to pick up signal at low drug concentrations, e.g., THC <4 pgfL.
The empirical values are realistic figures with reason- LOD and the origin) and if the intercept is well defined. If blank reading random error is normally distributed, the LOD is located at the concentration represented by the mean blank signal value plus 3 SD of that mean value. Statistically, the chance that the signal measured at the LOD is the result of a random fluctuation of the blank signal is only -0.13% (LOD confidence value, -99.86%).
However, the large imprecision values show that the assumptions necessary for the use of the statistical method do not hold for these assays. If the calibration curve were constructed with several points near the origin, then the slope of the curve in the low concentration range, the intercept, and the associated imprecision could be better defined and the statistical approach might be successfully employed. However, this approach is not particularly practical. The excessive variability of the statistical data can be explained by the values for negative controls collected during a typical month. For THC, nearly every negative sample is measured at "0" with only a rare non-0 value, resulting in huge CVs and less than optimal precision. For BE in a typical month, -20% of negatives are "0" and the rest of the values range from -1.0 to 1.6 gfL. sources, e.g., poor syringe cleaning, dirty septum or injection port liner. Contamination is a real possibility and can account for a negative control that registers a non-0 reading.
The majority of our THC-negative controls gave quantitative results of "0," showing that contamination was not a problem. However, from the empirical LOD data, a sample actually containing 1 pg/L THC will probably also give a result of "0," simply because this concentration is below the LOD. For BE, the majority of our negative controls had results between -1.0 and 1.6 tg1L-which could mean that analyte is actually present in the samples because of contamination.
However, because -20% of negative controls do yield "0" values as expected, internal standard impurity is probably not a significant problem. The empirical BE LOD data show that at least a few samples containing -3.0 g/L BE will be measured as "0"; moreover, some, if not all, of the non-0 negative control readings probably represent nothing other than noise. The statistical LODs and LOQs for amphetamines and opiates are both far below the corresponding empirical values because they are based on the analysis of blanks. Because the blank samples contain no drug, the ion ratios naturally fail the acceptability criteria. The empirical values, on the other hand, correspond to concentrations at which sufficient drug is present to yield acceptable ion ratios. For THC, ion ratios are valid down to -12% of cutoff; for BE and the opiates, to -7% of cutoff. For the amphetamines, ion ratios begin to fail at -25% of cutoff. The point at which ion ratios fail will vary from drug to drug, probably according to the amount of nondeuterated drug contaminating the internal standard.
It is highly inadvisable for a forensic laboratory using GC-MS for confirmation to set LOD or LOQ values at concentrations at which GC-MS acceptance criteria cannot be met. Every assay has a performance limit at the low and the high ends of its dynamic range. For clinical assays for which pure analyte preparations are not available for dilution studies, the statistical method may be practical. Stifi, use of the empirical approach with serial dilutions of actual patients' samples may be preferable for determining the LOD. If small quantities of analyte produce relatively large signal responses, the statistical method is more feasible.
For analytes such as some therapeutic drugs and vitamins, for which the presence of very small quantities of analyte is not of interest, the statistical method is also probably quite adequate.
We suggest that the choice of method for LOD determination be tailored to suit the characteristics of the assay and the purpose for which results in the region of the LOD will be used.
The analysis of negative samples is a very valuable practice, documenting the absence of carryover or contamination. Laboratories often require that results for negative controls be below the LOD to be acceptable. Also, negative controls can give results >0 but stifi be well below the empirical LOD, especially for drugs such as the amphetamines and opiates. Thus, it can be unclear whether the quantitative value is due to assay noise, carryover, or contamination.
The statistical approach can be used to set an upper limit of acceptability for negative controls. The statistical method provides a value that represents an upper confidence limit of -95-99% for the blank. A value higher than the statistical LOD concentration is likely due not to noise but to the presence of analyte.
For forensic confirmatory GC-MS assays for abused drugs, the statistical LOD method is an easy way to generate an LOD, but that value is likely to be artificially low. The empirical LOD method produces a number that represents the real limit of feasibility of an assay and a value that meets all routine analytical acceptance criteria. it is more logical to progressively decrease drug concentration until acceptance criteria fail than to measure blank samples and extrapolate upwards data that are doomed to fail acceptance criteria. As Needleman and Romberg pointed out, the ability to measure "nothing" is of questionable forensic utility.
